Radio-Pharmaceutical Probe for ROS Self-Monitoring

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(09): 0937
DOI: 10.1055/s-0042-1751992

Innovative Drug Discovery and Development

Contributor(s):

Dirk Trauner

,

Joseph A. Flores

radiotherapy - diselenide - fluorescent probe - reactive oxygen species - NIR-II

Article published online:
16 August 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany